Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Euthymics Bioscience
AddedFeb 15, 2024
UpdatedJun 18, 2026
Euthymics Bioscience

Euthymics Bioscience

Series A

Euthymics Bioscience: A neuroscience-focused company developing advanced treatments for depression and CNS disorders.

HQ
Cambridge, MA, US
Founded
2009
Overview
Compare
Fundraising
Employees

Euthymics Bioscience is a neuroscience-focused clinical-stage company dedicated to developing next-generation treatments for depression and central nervous system disorders. Their primary product, EB-1010, targets patients who do not respond adequately to SSRIs, aiming to improve efficacy and reduce side effects like weight gain, sexual dysfunction, and cognitive impairment.

Euthymics Bioscience has made significant strides in the field of depression treatment, leveraging cutting-edge research to address unmet medical needs. As a private Delaware corporation, the company is headquartered in Cambridge, Massachusetts. Their innovative approach has positioned them as a promising player in the neuroscience and pharmaceutical sectors.

Euthymics Bioscience - Similar Companies

Psy Therapeutics logo

Psy Therapeutics

psythx.com

Evecxia logo

Evecxia

evecxia.com

Eumentis Therapeutics logo

Eumentis Therapeutics

BioHealthonomics logo

BioHealthonomics

Synchroneuron logo

Synchroneuron

Aptinyx logo

Aptinyx

aptinyx.com

Neuronetics logo

Neuronetics

neurostar.com

Reset Pharmaceuticals logo

Reset Pharmaceuticals

MindSet Rx logo

MindSet Rx

Neuronascent logo

Neuronascent

neuronascent.com

Embera Neurotherapeutics logo

Embera Neurotherapeutics

emberaneuro.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

NeuroBionics logo

NeuroBionics

Kadmus Pharmaceuticals logo

Kadmus Pharmaceuticals

Epirus Biopharmaceuticals logo

Epirus Biopharmaceuticals

Euthymics Bioscience - Quick Facts

Who are Euthymics Bioscience's competitors?

Companies similar to Euthymics Bioscience include Psy Therapeutics, Evecxia, Eumentis Therapeutics and BioHealthonomics.

When was Euthymics Bioscience founded?

Euthymics Bioscience was founded in 2009.

Where is Euthymics Bioscience's headquarters located?

Euthymics Bioscience's headquarters is located in Cambridge, MA, US.

When was Euthymics Bioscience's last funding round?

Euthymics Bioscience's most recent funding round was for $10.5M (USD) in April 2014.

How much has Euthymics Bioscience raised to-date?

As of Apr 1, 2014, Euthymics Bioscience has raised a total of $38.5M (USD).

How many employees does Euthymics Bioscience have?

Euthymics Bioscience has 30 employees as of Feb 5, 2024.

Euthymics Bioscience - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research